articles about PCV2 in Articles

Hans Nauwynck: what is driving PCV2 evolution?

Professor Nauwynck has been researching PCV2 virus since the emergence of PCV2-associated diseases. PCV2 caused a serious crisis in global swine health that was ultimately addressed through the development and mass deployment of effective PCV2 vaccines. He is an excellent connoisseur of this small virus that continues to surprise us.

Hans Nauwynck: understanding viruses from the cell to the farm

Hans Nauwynck defines himself as a veterinary virologist, a person who works in a laboratory setting, doing precise work, like a surgeon, aiming to gain a better understanding of how animal viruses interact with their target cells. But it is much more. His deep understanding of the biological behavior of viruses allows him to fluently explain many of the “whys” that are so important for a better understading of the pathogenesis of viral diseases and the development of effective control strategies.

The microbiome and viral infections

07-Nov-2017

This article relates different microbiome profiles to greater or lesser severity in clinical signs, lesions and viral load in a co-infection with PRRS and PCV2 viruses, opening a window of opportunity.

Three months pigs with PCV2-SD. Note the marked spine, indicative of growth retardation, and body pallor

The challenge of Porcine Circovirus type 2 (PCV2) intra-specific taxonomic classification

All available vaccines in the European and North-American market are based on PCV2a genotype, while the most prevalent ones are PCV2b and PCV2d ones. Although significant level of cross-protection among these three genotypes has been demonstrated, it would be interesting to assess if vaccine efficiency would be equivalent in front of all these different genotypes.